Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
XORTX Therapeutics Inc
V.XRTX
Alternate Symbol(s):
XRTX
Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance...
its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:XRTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Comment by
SpaceLabs
on Nov 16, 2021 4:50am
RE:RE:RE:RE:RE:RE:Significantly Undervalued and Strong Buy
KOkidneydisease, PLEASE ANSWER?? 1. Do you have any PROOF that FUNDS with RRSP and TFSA money are investing in XORTX.??? 2. Do you approve an IDIOT CEO on Nasdaq who DISCOUNTED IPO by 30% for these
...more
(2)
•••
KOkidneydisease
X
View Profile
View Bullboard History
Comment by
KOkidneydisease
on Nov 16, 2021 2:25am
RE:RE:RE:RE:RE:Significantly Undervalued and Strong Buy
I'm not promoting this company to anyone. If you reread my previous post I'm merely stating a fact, that FUNDS with RRSP and TFSA money are investing in XORTX. These funds are managed by
...more
(54)
•••
Richmond
X
View Profile
View Bullboard History
Comment by
Richmond
on Nov 16, 2021 1:28am
RE:RE:RE:RE:Significantly Undervalued and Strong Buy
Don't promote this sick company to new and young investors yo out it their RRSP or Tax Free Savings into this shittt...
(2)
•••
KOkidneydisease
X
View Profile
View Bullboard History
Comment by
KOkidneydisease
on Nov 15, 2021 6:24pm
RE:RE:RE:Significantly Undervalued and Strong Buy
Hey Ankle, you're right about the others doing their own DD on their investments but I feel bad for them all the same so I'll just throw some rationale out there for them. The last 2
...more
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Comment by
SpaceLabs
on Nov 15, 2021 5:56pm
RE:JUST ANOTHER WORTHLESS PUMP FROM THE BEST!
ABcd42 likes CEO and his LEAKS. A No Name Brand Financier in NY got 30% DISCOUNT only to MANIPULATE, PUMP it and then BENNY style DUMP it on Dr. acting as XRX CEO. Allen ! ,, for the shareholders, we
...more
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Nov 15, 2021 5:35pm
JUST ANOTHER WORTHLESS PUMP FROM THE BEST!
BOB & PENNY, THEY SELL TO YOU IDIOTS !!! KEEP BUYING....
(54)
•••
Richmond
X
View Profile
View Bullboard History
Comment by
Richmond
on Nov 15, 2021 1:53pm
RE:RE:RE:Argus Report: Analysts TARGET C$16, read TODAY's NR, WOW !
I AGREE AB42. Xirtex Executives are Full of Shiitts!!!. This Shiittt can't go over $4, Let alone $16.00. THESE SKUNKS ARE CROOKS. Don't invest in XORTEX!!! LIARS!!!!. you'll be sorry like
...more
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Comment by
SpaceLabs
on Nov 15, 2021 1:48pm
RE:RE:Argus Report: Analysts TARGET C$16, read TODAY's NR, WOW !
ABcd, you sounding Gaga GooGoo today, I am not Bullish AT ALL as long as this Dr. CEO runs the show on Nasdaq/TSX. I want him to devote ALL his TIME to PRODUCT DEVELOPMENT and let a seasoned CEO take
...more
(1)
•••
Anklebiter42
X
View Profile
View Bullboard History
Comment by
Anklebiter42
on Nov 15, 2021 12:01pm
RE:Argus Report: Analysts TARGET C$16, read TODAY's NR, WOW !
Wait a minute Spacelab..... I thought you were heading to the rat poision coins? Green day and your all of a sudden bullish. You flip-flop more than a politician. HAHA. Does the CEO still have to
...more
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Post by
SpaceLabs
on Nov 15, 2021 11:49am
Argus Report: Analysts TARGET C$16, read TODAY's NR, WOW !
Argus Research Initiates Equity Research Report Coverage on XORTX Therapeutics Inc. (Nasdaq: XRTX)
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Comment by
SpaceLabs
on Nov 15, 2021 10:58am
RE:Insider Buys
Ask CEO and ABcd, they have INSIDER Info or contact RoadRunners ,XRX Marathon in NY. Tanking daily, no bottom yet, waiting for the Analyst REPORTS from NY
(10)
•••
yrunvs
X
View Profile
View Bullboard History
Post by
yrunvs
on Nov 15, 2021 5:37am
Insider Buys
Anybody picking up shares while sp is low? Just curious....
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Post by
SpaceLabs
on Nov 14, 2021 8:25pm
Analyst R'port/ a SPIKE $$/ Overallotmnt/ No Hold/Sell it $$
I am waiting for UTube comments made by CEO Allen of XRTX/ NASDAQ that Analysts Reports are in the works and will be RELEASED SOON in November,,,,,, I hope ONLY to prevent our/ XRX shares from a
...more
(1)
•••
Anklebiter42
X
View Profile
View Bullboard History
Comment by
Anklebiter42
on Nov 14, 2021 8:17pm
RE:RE:RE:$2 by end of December
Spacelab. My prediction......One more week of the Investor roadshow. By the end of the week, David will have transfered the rest of your shares to his institional buddies. The following week the stock
...more
(64)
•••
SpaceLabs
X
View Profile
View Bullboard History
Comment by
SpaceLabs
on Nov 14, 2021 7:52pm
RE:RE:$2 by end of December
ABcd, a gaga googoo, ONE MAN CANNOT MASTER TWO SHIPS, 30% DISCOUNT to a ROADRUNNER FINANCIER for $4/share. Tell your friend CEO ALLEN to STEP DOWN now bcos we are Listed on NASDAQ my friend. ABcd
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle
New electric industrial heat technology to reduce greenhouse gas emissions
Discover Options Trading Strategies to Minimize your Tax Burden